For in vivo imagery using CCD camera, it is better to use lumniscence as compared to fluorescence. Among fluorescent reporters mCherry is superior to GFP. GFP frequencey has issues due to body's autofluorescence. I had once tested plasmids expressing GFP, mCherry, and firefly luciferase. Firefly luciferase is best followed by mCherry. You will get a lot of background fluorescence when using GFP, due autofluorescence.
Depends on your experimental design, and the optical imaging equipment (any of the IVIS?), but the golden rule for in vivo (animal imaging) is - never use GFP.
Yes you can! if you use balb/c mice, there will be lesser auto fluorescence compared to Black 6 mice. If your animal choice itself different better you try with FAR RED FPs
I have tested in both Balb/C and nude mice with IVIS machine. GFP is simply no good. I had injected plasmids into muscle. If you are working on a tumor or cancer model and your cells are located deeper, Luciferase may be a better option. However, as substrate has to be injected I/P, it may add to some variability which will have to be controlled.
It is possible to image GFP and autofluorescence does not need to need a limiting factor, particularly if you use time-domain optical imaging (McCormack E et al. Mol. Imaging 2007) or spectral unmixing whereby autofluorescence can be gated out. The major limitation with GFP is due to absorption of both excitation and emission spectra by haemoglobin or deoxyhaemoglobin. Thus, one should choose a reporter with ideally excitation and emission in the NIR. The main flaw with these far-red fluorescent proteins is that they generally are not very bright in comparison to GFP for in vivo imaging. But of course it depends on what your going to be looking at in vivo. If we are talking about superficial organs you might be able to use a fluorescent protein with high enough gene expression. If you want to go below 2-3 mm I would use a luciferase or nitroreductase reporter.
If you wish to continue with your current protocol, I would suggest investigating RFP or the newer IFP - both are generally better for in vivo use than GFP. However, depending on the depth of your target, it is possible to devise an effective spectral unmixing protocol that will minimize autofluorescent effects...but not eliminate them completely. Look at the attached image - you can see the issues you have to deal with when using GFP...
One additional to Emmet McCormack's point about the NIR dyes not being as bright - oftentimes this is as much a factor of the detector than it is of the dye itself, as many CCDs have a dramatic dropoff in Quantum Efficiency starting around 650nm...so it is also important to match your dye with a) your camera's peak efficiency, and b) an appropriate filter ex/em set.
Please read the post again, I never said NIR dyes are not as bright - I said far red fluorescent proteins are not as bright. I have tried this both with your system (CCD based) and the Optix, and while the PMT based Optix is better for NIR fluorescence in comparison to CCD, theres no disputing the fact that I can achieve higher expression of GFP in my cells than RFP with our vectors so as to affect my imaging results. (Please note that Im using "i" and "my"...so Im not generalizing for anyone other than myself). However, our group have used the Nitroreductase NIR imaging platform (using a quenched NIR dye) and find this to be superior to fluorescent protein and luciferase imaging in our models of disseminated and metastatic cancer (McCormack et al Cancer Res 2013).
No we havent tried it yet. We do lots of Heme and metastatic models so I need something that works in these models and Ive only seen good SC imaging with IFP so far really. Its great that its NIR but probably needs a few more rounds of mutation to be optimized for in vivo imaging of mets.
I know this is an old thread but I just want to provide some clarification in case others have a similar question. For reference, I'm a field application scientist for the IVIS instruments.
We *never recommend GFP for in vivo imaging. There's too much tissue autofluorescence and the spectra of GFP overlaps almost completely with peak tissue autofluorescence making it difficult to separate the signals even using spectral unmixing. Sometimes you can see GFP signal ex vivo but in vivo is very difficult.
I agree with statements above that firefly luciferase would be a much better choice.
Using a GFP-tagged gene for in vivo imaging experiments is indeed a feasible and widely employed technique in biological research. Green Fluorescent Protein (GFP) serves as a fluorescent marker, allowing the visualization of protein localization and dynamics in live organisms. Here are key considerations for using GFP-tagged genes in in vivo imaging:
Expression Level of GFP-Tagged Protein: Ensure that the GFP-tagged gene is expressed at levels sufficient for detection. The expression level can be influenced by the promoter used and the integration site of the gene in the genome.
Fluorescence Detection Equipment: The equipment used for imaging, such as fluorescence microscopes or in vivo imaging systems, should be capable of detecting GFP fluorescence. It's important to have the appropriate filters and detectors for GFP’s excitation and emission wavelengths (around 488 nm and 507 nm, respectively).
Biological Context: Consider the biological system in which you are working. GFP tagging is suitable for a wide range of organisms, from bacteria to mammals, but the effectiveness can vary depending on tissue penetration, autofluorescence of the organism, and the specific cellular environment.
Protein Functionality: Verify that the GFP tag does not disrupt the normal function of the protein. In some cases, the addition of GFP can affect protein folding, localization, or interactions with other molecules.
Phototoxicity and Photobleaching: Be aware of potential phototoxicity and photobleaching during prolonged exposure to the excitation light. These factors can impact cell viability and fluorescence intensity over time.
Spatial and Temporal Resolution: Assess whether the spatial and temporal resolution of GFP fluorescence is adequate for your experimental goals. GFP fluorescence might not be suitable for visualizing fast-moving or very small subcellular structures.
Controls and Validation: Include appropriate controls, such as cells or organisms that express GFP alone, to distinguish specific from nonspecific fluorescence signals. Validating the expression and localization of the GFP-tagged protein using complementary techniques, such as Western blotting or immunofluorescence with different markers, is also advisable.
Ethical Considerations: If the in vivo experiments are conducted in animals, ensure compliance with all ethical guidelines and institutional regulations for animal research.
Data Analysis and Interpretation: Analyze the imaging data carefully, taking into account factors like signal-to-noise ratio and potential artifacts. Interpret the results within the context of the biological system and the experimental conditions.
In summary, GFP-tagged genes can be effectively used for in vivo imaging, providing valuable insights into protein dynamics and function in live organisms. However, careful experimental design, consideration of technical limitations, and thorough validation are essential for obtaining accurate and meaningful results.
This protocol list might provide further insights to address this issue.